Mouwasat Medical Services Company (4002.SR)
SAR 88.2
(-0.34%)
SAR 88.2
(-0.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.7 Billion | 2.33 Billion | 2.14 Billion | 2.04 Billion | 1.85 Billion | 1.67 Billion |
| Cost of Revenue | 1.39 Billion | 1.23 Billion | 1.14 Billion | 1.08 Billion | 1.02 Billion | 903.52 Million |
| Gross Profit | 1.31 Billion | 1.09 Billion | 995.77 Million | 960.29 Million | 829.27 Million | 773.49 Million |
| Operating Expenses | 537.83 Million | 435.84 Million | 373.84 Million | 382.46 Million | 358.78 Million | 369.43 Million |
| Selling, General and Administrative Expenses | 546.5 Million | 99.36 Million | 78.47 Million | 77.05 Million | 85.68 Million | 61.56 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -8.67 Million | 336.47 Million | 295.37 Million | 305.4 Million | 273.1 Million | 7.18 Million |
| Cost and Expenses | 1.94 Billion | 1.67 Billion | 1.52 Billion | 1.46 Billion | 1.38 Billion | 1.27 Billion |
| Operating Income | 756.85 Million | 663.09 Million | 621.92 Million | 577.83 Million | 470.48 Million | 404.06 Million |
| Interest Expense | 46.45 Million | 22.88 Million | 8.19 Million | 14.03 Million | 20.15 Million | 6.13 Million |
| Income Tax Expense | 38.69 Million | 27.58 Million | 21.73 Million | 15.24 Million | 13.46 Million | 24.38 Million |
| Earnings before Tax | 727.08 Million | 660.27 Million | 632.19 Million | 576.86 Million | 462.23 Million | 408.69 Million |
| Net Income | 657.68 Million | 599.3 Million | 578.16 Million | 528.15 Million | 421.02 Million | 360.2 Million |
| Earnings Per Share Basic | 3.29 | 3.00 | 2.89 | 2.64 | 2.11 | 1.80 |
| Earnings Per Share Diluted | 3.29 | 3.00 | 2.89 | 2.64 | 2.11 | 1.80 |
| Weighted Average Shares Outstanding | 200 Million | 200 Million | 200 Million | 200 Million | 200 Million | 200 Million |
| Weighted Average Shares Outstanding (Diluted) | 200 Million | 200 Million | 200 Million | 200 Million | 200 Million | 200 Million |
| Gross Margin | 0.49 | 0.47 | 0.46 | 0.47 | 0.45 | 0.46 |
| EBIT Margin | 0.36 | 0.37 | 0.37 | 0.36 | 0.34 | 0.31 |
| Profit Margin | 0.24 | 0.26 | 0.27 | 0.26 | 0.23 | 0.21 |
| EBITDA | 986.81 Million | 861.81 Million | 787.44 Million | 735.09 Million | 623.71 Million | 521.17 Million |
| Earnings Before Tax Margin | 0.28 | 0.28 | 0.29 | 0.28 | 0.25 | 0.24 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 710.74 Million | 690.3 Million | 722.78 Million | 773.06 Million | 2.7 Billion | 640.89 Million |
| Cost of Revenue | 392.81 Million | 382.87 Million | 376.95 Million | 378.49 Million | 1.39 Billion | 342.73 Million |
| Gross Profit | 317.93 Million | 307.43 Million | 345.82 Million | 394.56 Million | 1.31 Billion | 298.15 Million |
| Operating Expenses | 150.15 Million | 131.22 Million | 153.32 Million | 75.61 Million | 556.22 Million | 115.86 Million |
| Selling, General and Administrative Expenses | - | 120.38 Million | 153.32 Million | -248.71 Million | - | 115.86 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -150.15 Million | -131.22 Million | 2.78 Million | -3.32 Million | -556.22 Million | 2.87 Million |
| Cost and Expenses | 542.96 Million | 514.1 Million | 530.28 Million | 378.49 Million | 1.94 Billion | 458.59 Million |
| Operating Income | 167.78 Million | 176.2 Million | 192.49 Million | 394.56 Million | 756.86 Million | 182.29 Million |
| Interest Expense | - | 8.01 Million | 8.54 Million | 11.68 Million | 46.45 Million | 11.39 Million |
| Income Tax Expense | -149.64 Million | 11.84 Million | 13.81 Million | 5.12 Million | 38.69 Million | 11.13 Million |
| Earnings before Tax | - | 170.7 Million | 189.38 Million | 197.64 Million | 727.08 Million | 174.67 Million |
| Net Income | 149.64 Million | 152.69 Million | 171.58 Million | 184.16 Million | 657.68 Million | 156.37 Million |
| Earnings Per Share Basic | 0.75 | 0.76 | 0.86 | 0.92 | - | 0.78 |
| Earnings Per Share Diluted | 0.75 | 0.76 | 0.86 | 0.92 | - | 0.78 |
| Weighted Average Shares Outstanding | 200 Million | 200.91 Million | 200 Million | 200 Million | 200 Million | 200 Million |
| Weighted Average Shares Outstanding (Diluted) | 200 Million | 200.91 Million | 200 Million | 200 Million | 200 Million | 200 Million |
| Gross Margin | 0.45 | 0.45 | 0.48 | 0.51 | 0.49 | 0.47 |
| EBIT Margin | 0.24 | 0.36 | 0.35 | 0.35 | - | 0.38 |
| Profit Margin | 0.21 | 0.22 | 0.24 | 0.24 | 0.24 | 0.24 |
| EBITDA | 167.78 Million | 249.3 Million | 250.89 Million | 266.97 Million | - | 242.2 Million |
| Earnings Before Tax Margin | 0.24 | 0.26 | 0.27 | 0.51 | 0.28 | 0.28 |
5211
300205
5285
FR
GXYEF
ABG